Stockreport

What Disc Medicine (IRON)'s Bitopertin Fast-Track Review and Rising R&D Spend Mean for Shareholders [Yahoo! Finance]

Disc Medicine, Inc.  (IRON) 
PDF by the receipt of the FDA Commissioner's National Priority Voucher for expedited review, and reported increased research and development spending in its latest quarterly [Read more]